Cargando…
Dual-release hydrocortisone treatment: glycometabolic profile and health-related quality of life
OBJECTIVE: Adrenal insufficiency (AI) is a chronic condition associated with increased mortality and morbidity. The treatment of AI in the last years has been object of important changes due to the development of a dual-release preparation of hydrocortisone. It differs from previous therapeutic stra...
Autores principales: | Mongioì, L M, Condorelli, R A, La Vignera, S, Calogero, A E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793805/ https://www.ncbi.nlm.nih.gov/pubmed/29233815 http://dx.doi.org/10.1530/EC-17-0368 |
Ejemplares similares
-
Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency
por: Gasco, V., et al.
Publicado: (2022) -
Chronic Administration of Tadalafil Improves the Symptoms of Patients with Amicrobic MAGI: An Open Study
por: La Vignera, Sandro, et al.
Publicado: (2017) -
Diabetes Mellitus and Infertility: Different Pathophysiological Effects in Type 1 and Type 2 on Sperm Function
por: Condorelli, Rosita A., et al.
Publicado: (2018) -
FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies
por: Cannarella, Rossella, et al.
Publicado: (2019) -
Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility
por: Cannarella, Rossella, et al.
Publicado: (2020)